OUR GROUP BRANDS




Microorganism based Bio-Fertilizers and Bio-pest controllers
Power Electronics Products and Solutions
LATEST UPDATES
Inclusive Growth : To be the most trusted organization for all stakeholders achieving excellence, being socially responsible and unlocking value resulting in inclusive growth
OUR VISION
To identify and aggregate MSMEs having high potential and expertise, facilitating vertical growth, unlocking value, while complimenting the existing promoters, who shall continue to manage, being at helm of affairs
OUR MISSION
The Trading Window is closed for Q1 (2023-24) results announcement, from 01-July-2023 until 48 hours after the financial result for quarter ending 30th June 2023 is announced
14 Jun 2023
The Notice for AGM 2023, to be conducted on September 20,2023, along with Annual report, notification on book closure and other associated documents has been published
NCLT, Chennai, has approved the Resolution plan submitted by IBL Healthcare Limited, a wholly owned subsidiary of IBL.
M/s. KNISS LABORATORIES PRIVATE LIMITED has become a subsidiary of M/s. IBL Healthcare Limited, a wholly owned subsidiary of IBL
IBL has announced the financial results for quarter and year ending 31 Mar 2023
29 Aug 2023
25 Aug 2023
25 Aug 2023
29 Jun 2023
IBL Healthcare Limited, a wholly owned subsidiary of IBL, acquires 36.92% equity in M/S Peekay Mediequip Limited, a medical equipment manufacturer, as a first step towards making it a subsidiary
13 Jul 2023


Disposable Syringes




Pharma Manufacturing
Pharma Marketing
Healthcare and Pharma Services




Agri Solutions
Real Estate Infra Promotion




CSR Services
Investment


Pharma Retail
